EOS Energy is racing to scale a zinc-based grid battery that aims to be safer and simpler than today’s mainstream designs, with a big tailwind from US incentives and growing demand from power-hungry data centers. The catch is a tangled financing setup and heavy dependence on a few customers that could leave regular shareholders diluted—or worse—if growth stumbles.Read more

Supernus Pharmaceuticals is betting that growing demand for brain and nervous system treatments—and a newer Parkinson’s medicine—can reignite growth and improve profitability. The flip side is a business still leaning heavily on a couple of key drugs while pricing pressure, rising spending, and tougher competition could derail that story.Read more

UiPath is betting that new AI-powered automation tools and deeper partnerships with big tech and consulting firms will help it win more work from existing customers and open up new markets. But deal delays, customer budget caution, and the shift toward a subscription model could weigh on results in the near term.Read more